Dr. Boni is the Board Member at ClearCount. He currently serves as the deputy director of Donald H. Jones Center for Entrepreneurship and John R. Thorne Professor of Entrepreneurship at Carnegie Mellon University. He contributes decades of experience of funding and managing successful start-ups in the biomedical industry. Dr. Boni was the founding CEO of PSI Medical, Inc. which developed an FDA approved minimally invasive surgical device for treating kidney stones. He was also the founding CEO of SynAx Pharmaceuticals, Inc., a drug development company specializing in central nervous system drugs. He was also managing director and CEO of SciVision, a joint venture company that developed and marketed molecular modeling and associated applications software. Dr. Boni holds a BS in Mechanical Engineering from Carnegie Mellon University, an MS in Mechanical Engineering from the University of Southern California, and a Ph.D. in Engineering Science and Physics from UC San Diego. He also serves as an Advisor at Pittsburgh Equity Partners.